Ji Sim Yoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ji Sim Yoon has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Il Kim
Surgical Mind Inc., Seoul 07547, Republic of Korea
1 shared publication - Jeong Hee Hong
Department of Nursing Samsung Medical Center Seoul Republic of Korea
1 shared publication - Junsang Yoo
Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul 06355, Republic of Korea
1 shared publication - Meong Hi Son
Samsung Medical Center, Sungkyunkwan University School of Medicine
1 shared publication - Min-Jeoung Kang
Department of Medicine, Division of General Internal Medicine, Brigham and Women’s Hospital
1 shared publication - Nathan Lucien Vieira
Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University, Seoul 06351, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 12 November 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (22) , 12002
Development and Evaluation of a Next-Generation Medication Safety Support System Based on AI and Mixed Reality: A Study from South Korea
Medication errors pose a significant threat to patient safety. Although Bar-Code Medication Administration (BCMA) has reduced error rates, it is constrained by handheld devices, workflow interruptions, and incomplete safeguards against wrong patients, wrong doses, or drug incompatibility. In this study, we developed and evaluated a next-generation BCMA system by integrating artificial intelligence and mixed reality technologies for real-time safety checks: Optical Character Recognition verifies medication–label concordance, facial recognition confirms patient identity, and a rules engine evaluates drug–diluent compatibility. Computer vision models achieved high recognition accuracy for drug vials (100%), medication labels (90%), QR codes (90%), and patient faces (90%), with slightly lower performance for intravenous fluids (80%). A mixed-methods evaluation was conducted in a simulated environment using the System Usability Scale (SUS), Reduced Instructional Materials Motivation Survey (RIMMS), Virtual Reality Sickness Questionnaire (VRSQ), and NASA Task Load Index (NASA-TLX). The results indicated excellent usability (median SUS = 82.5/100), strong user motivation (RIMMS = 3.7/5), minimal cybersickness (VRSQ = 0.4/6), and manageable cognitive workload (NASA-TLX = 31.7/100). Qualitative analysis highlighted the system’s potential to streamline workflow and serve as a digital “second verifier.” These findings suggest strong potential for clinical integration, enhancing medication safety at the point of care.
- 12 November 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (22) , 12002
Open AccessDevelopment and Evaluation of a Next-Generation Medication Safety Support System Based on AI and Mixed Reality: A Study from South Korea
Medication errors pose a significant threat to patient safety. Although Bar-Code Medication Administration (BCMA) has reduced error rates, it is constrained by handheld devices, workflow interruptions, and incomplete safeguards against wrong patients, wrong doses, or drug incompatibility. In this study, we developed and evaluated a next-generation BCMA system by integrating artificial intelligence and mixed reality technologies for real-time safety checks: Optical Character Recognition verifies medication–label concordance, facial recognition confirms patient identity, and a rules engine evaluates drug–diluent compatibility. Computer vision models achieved high recognition accuracy for drug vials (100%), medication labels (90%), QR codes (90%), and patient faces (90%), with slightly lower performance for intravenous fluids (80%). A mixed-methods evaluation was conducted in a simulated environment using the System Usability Scale (SUS), Reduced Instructional Materials Motivation Survey (RIMMS), Virtual Reality Sickness Questionnaire (VRSQ), and NASA Task Load Index (NASA-TLX). The results indicated excellent usability (median SUS = 82.5/100), strong user motivation (RIMMS = 3.7/5), minimal cybersickness (VRSQ = 0.4/6), and manageable cognitive workload (NASA-TLX = 31.7/100). Qualitative analysis highlighted the system’s potential to streamline workflow and serve as a digital “second verifier.” These findings suggest strong potential for clinical integration, enhancing medication safety at the point of care.